ALEMS Stock Overview
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
European Medical Solutions Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.019 |
| 52 Week High | €0.037 |
| 52 Week Low | €0.0024 |
| Beta | 0.54 |
| 11 Month Change | 0% |
| 3 Month Change | -5.00% |
| 1 Year Change | 5.56% |
| 33 Year Change | -91.59% |
| 5 Year Change | -93.89% |
| Change since IPO | -99.72% |
Recent News & Updates
Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?
Jun 15
DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward
Dec 21Recent updates
Shareholder Returns
| ALEMS | BE Biotechs | BE Market | |
|---|---|---|---|
| 7D | 0% | 2.9% | 0.7% |
| 1Y | 5.6% | 5.3% | 3.0% |
Return vs Industry: ALEMS matched the Belgian Biotechs industry which returned 5.3% over the past year.
Return vs Market: ALEMS exceeded the Belgian Market which returned 3% over the past year.
Price Volatility
| ALEMS volatility | |
|---|---|
| ALEMS Average Weekly Movement | 5.7% |
| Biotechs Industry Average Movement | 7.5% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in BE Market | 6.4% |
| 10% least volatile stocks in BE Market | 2.3% |
Stable Share Price: ALEMS's share price has been volatile over the past 3 months compared to the Belgian market.
Volatility Over Time: ALEMS's weekly volatility has decreased from 11% to 6% over the past year, but is still higher than 75% of Belgian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 125 | Samuel Sancerni | www.dms-imaging.com |
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024.
European Medical Solutions Fundamentals Summary
| ALEMS fundamental statistics | |
|---|---|
| Market cap | €28.30m |
| Earnings (TTM) | -€1.07m |
| Revenue (TTM) | €43.93m |
0.6x
P/S Ratio-26.4x
P/E RatioIs ALEMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALEMS income statement (TTM) | |
|---|---|
| Revenue | €43.93m |
| Cost of Revenue | €28.45m |
| Gross Profit | €15.48m |
| Other Expenses | €16.55m |
| Earnings | -€1.07m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00072 |
| Gross Margin | 35.23% |
| Net Profit Margin | -2.44% |
| Debt/Equity Ratio | 133.4% |
How did ALEMS perform over the long term?
See historical performance and comparison